Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy

• المؤلفون الرئيسيون: Hermawan, Adam, Putri, Herwandhani
• التنسيق: مقال PeerReviewed
• اللغة: English
• منشور في: Springer 2022
• الموضوعات: Pharmaceutical Sciences
• الوصول للمادة أونلاين: https://repository.ugm.ac.id/278720/1/Hermawan_FA.pdf; https://repository.ugm.ac.id/278720/; https://bmcgenomdata.biomedcentral.com/articles/10.1186/s12863-022-01086-2; https://doi.org/10.1186/s12863-022-01086-2
• المؤسسة: Universitas Gadjah Mada

Background: Several studies have demonstrated the antitumor activity of rosiglitazone (RGZ) in cancer cells, includ- ing breast cancer cells. However, the molecular targets of RGZ in the inhibition of angiogenesis in breast cancer cells remain unclear. This study aimed to explore the potential tar...